| Literature DB >> 35350717 |
LaKrista Morton1,2,3, Kevin Stelfox1,2,3, Marcus Beasley1,2,3, Gareth T Jones1,2,3, Gary J Macfarlane1,2,3, Peter Murchie4, John Paton5, Rosemary Hollick1,2,3.
Abstract
Objectives: To understand the impact of the coronavirus disease 2019 pandemic on access to healthcare services for patients with inflammatory and non-inflammatory musculoskeletal (MSK) conditions.Entities:
Keywords: COVID-19; PsA; axial spondyloarthritis; healthcare; pain
Year: 2022 PMID: 35350717 PMCID: PMC8946474 DOI: 10.1093/rap/rkac013
Source DB: PubMed Journal: Rheumatol Adv Pract ISSN: 2514-1775
Sociodemographic characteristics of respondents to the questionnaire, stratified by cohort (n = 1054)
| Characteristics | Study cohort | |||
|---|---|---|---|---|
| BSRBRAS | MAmMOTH | BSR-PsA | ||
| ( | ( | ( | ||
| Age, median (IQR), years | 57 (44–67) | 64 (54–73) | 55 (46–64) | |
| Gender, | Male | 392 (65.8) | 118 (39.9) | 67 (41.4) |
| Female | 203 (34.1) | 177 (59.8) | 95 (58.6) | |
| Non-binary | 1 (0.2) | 1 (0.3) | 0 (0.0) | |
| Employment status, | Full time, including students and unpaid | 245 (41.1) | 86 (29.1) | 72 (44.4) |
| Working part time | 88 (14.8) | 22 (11.2) | 28 (17.3) | |
| Retired | 174 (29.2) | 149 (50.3) | 36 (22.2) | |
| Unemployed, seeking work | 13 (2.2) | 3 (1.0) | 1 (0.6) | |
| Unemployed because of ill health/disability | 22 (3.7) | 4 (1.4) | 14 (8.6) | |
| Retired early because of ill health/disability | 43 (7.2) | 14 (4.7) | 8 (4.9) | |
| Missing | 11 (1.9) | 7 (2.4) | 3 (1.9) | |
| Deprivation, | 1, most deprived | 61 (10.2) | 15 (5.1) | 19 (11.7) |
| 2 | 90 (15.1) | 21 (7.1) | 23 (14.2) | |
| 3 | 111 (18.6) | 61 (20.6) | 38 (23.5) | |
| 4 | 164 (27.5) | 113 (38.2) | 39 (24.1) | |
| 5, least deprived | 170 (28.5) | 86 (29.1) | 43 (26.5) | |
| Residence, | Urban | 435 (73.0) | 181 (61.1) | 121 (74.7) |
| Rural | 161 (27.0) | 115 (38.9) | 41 (25.3) | |
| Month of completion (2020), | July | 257 (43.1) | 143 (48.3) | 48 (29.6) |
| August | 161 (27.0) | 18 (6.1) | 51 (31.5) | |
| September | 18 (3.0) | 9 (3.0) | 7 (4.3) | |
| October | 149 (25.0) | 119 (40.2) | 55 (34.0) | |
| November | 9 (1.5) | 7 (2.4) | 1 (0.6) | |
| December | 2 (0.3) | 0 (0.0) | 0 (0.0) | |
| Medications, | bDMARDs | 234 (39.2) | 7 (2.4) | 51 (31.5) |
| tsDMARDs | 39 (6.5) | 8 (2.7) | 26 (16.0) | |
| cDMARDs | 80 (13.4) | 14 (4.7) | 95 (58.6) | |
| Steroids | 44 (7.4) | 39 (13.2) | 19 (11.7) | |
| Missing | 17 (2.9) | 10 (3.4) | 8 (4.9) | |
Attempts at seeking healthcare during the pandemic
| Type of care | Appointment outcome | n (%) |
|---|---|---|
| Any healthcare ( | Had an appointment go ahead as planned | 405 (67.3) |
| Had an appointment delayed | 156 (25.9) | |
| Had an appointment cancelled | 199 (33.1) | |
| Tried but unable to book appointment | 166 (27.6) | |
| General practice ( | Had an appointment go ahead as planned | 301 (71.7) |
| Had an appointment delayed | 42 (10.0) | |
| Had an appointment cancelled | 39 (9.3) | |
| Tried but unable to book appointment | 95 (22.6) | |
| Hospital appointment/treatment session ( | Had an appointment go ahead as planned | 217 (49.5) |
| Had an appointment delayed | 133 (30.4) | |
| Had an appointment cancelled | 180 (41.1) | |
| Tried but unable to book appointment | 66 (15.1) |
Factors associated with attempting to access primary care (N = 1011)
| Characteristics | Attempted to access primary care, | OR (95% CI) | Age and gender, aOR (95% CI) | Age, gender and deprivation, aOR (95% CI) | |
|---|---|---|---|---|---|
| Age (years) | ≥30 | 15 (62.5) |
|
|
|
| 31–45 | 93 (44.7) | 1.29 (0.92, 1.81) | 1.26 (0.90, 1.76) | 1.30 (0.93, 1.83) | |
| 46–64 | 164 (38.5) | 1 [ref] | 1 [ref] | 1 [ref] | |
| 65–74 | 100 (42.0) | 1.16 (0.84, 1.60) | 1.19 (0.86, 1.65) | 1.20 (0.87, 1.67) | |
| ≥75 | 48 (41.7) | 1.14 (0.75, 1.74) | 1.21 (0.79, 1.85) | 1.21 (0.79, 1.84) | |
| Gender | Male | 211 (38.3) |
|
| 0.78 (0.60, 1.01) |
| Female | 208 (45.4) | 1 [ref] | 1 [ref] | 1 [ref] | |
| Study cohort | BSRBR-AS | 220 (38.5) | 1 [ref] | 1 [ref] | 1 [ref] |
| MAmMOTH | 130 (45.6) |
| 1.32 (0.97, 1.79) | 1.29 (0.94, 1.75) | |
| BSR-PsA | 70 (45.5) | 1.33 (0.93, 1.91) | 1.32 (0.91, 1.90) | 1.32 (0.91, 1.91) | |
| Deprivation | 1, most deprived | 35 (38.5) | 0.95 (0.58, 1.54) | 0.89 (0.54, 1.47) | 0.89 (0.55, 1.47) |
| 2 | 49 (37.7) | 0.92 (0.60, 1.41) | 0.92 (0.60, 1.41) | 0.92 (0.60, 1.41) | |
| 3 | 91 (44.8) | 1.23 (0.86, 1.78) | 1.23 (0.85, 1.78) | 1.23 (0.85, 1.78) | |
| 4 | 133 (43.6) | 1.17 (0.84, 1.63) | 1.20 (0.86, 1.68) | 1.20 (0.86, 1.68) | |
| 5, least deprived | 112 (39.7) | 1 [ref] | 1 [ref] | 1 [ref] | |
| Employment ( | Full time, including students and unpaid | 152 (38.7) | 1 [ref] | 1 [ref] | 1 [ref] |
| Part time | 63 (43.2) | 1.20 (0.82, 1.77) | 1.19 (0.79, 1.78) | 1.19 (0.79, 1.78) | |
| Retired | 146 (41.5) | 1.12 (0.84, 1.51) | 1.27 (0.79, 2.03) | 1.29 (0.80, 2.08) | |
| Unemployed, seeking work; unemployed/retired early due to ill health | 56 (48.3) | 1.48 (0.98, 2.25) |
|
| |
| Residence | Urban | 292 (41.4) | 1 [ref] | 1 [ref] | 1 [ref] |
| Rural | 128 (41.8) | 1.02 (0.77, 1.34) | 1.02 (0.78, 1.35) | 0.94 (0.70, 1.25) | |
| Shielded ( | Advised and followed | 148 (44.4) | 1.19 (0.91, 1.55) | 1.19 (0.91, 1.56) | 1.20 (0.92, 1.57) |
| Not advised or not followed | 264 (40.2) | 1 [ref] | 1 [ref] | 1 [ref] | |
| Month of completion, 2020 | July | 162 (37.8) | 1 [ref] | 1 [ref] | 1 [ref] |
| August, September | 99 (39.3) | 1.07 (0.77, 1.47) | 1.09 (0.79, 1.50) | 1.07 (0.78, 1.48) | |
| October–December | 159 (48.2) |
|
|
| |
| Medication ( | bDMARD or tsDMARD | 146 (45.8) |
|
|
|
| cDMARD or steroids only | 77 (46.4) | 1.43 (1.00, 2.03) |
|
| |
| None of the above | 197 (37.7) | 1 [ref] | 1 [ref] | 1 [ref] | |
| PROMIS anxiety ( | Normal | 210 (36.6) | 1 [ref] | 1 [ref] | 1 [ref] |
| Mild | 110 (48.3) |
|
|
| |
| Moderate/severe | 96 (49.2) |
|
|
| |
| PROMIS depression ( | Normal | 238 (38.1) | 1 [ref] | 1 [ref] | 1 [ref] |
| Mild | 75 (44.4) | 1.30 (0.92, 1.83) | 1.27 (0.90, 1.80) | 1.29 (0.91, 1.82) | |
| Moderate/severe | 99 (51.0) |
|
|
| |
| EQ-5D | 0.64 (0.23) |
|
|
| |
EQ-5D: European Quality of Life 5-Dimensions questionnaire; ref: reference.
Mean (s.d.).
OR is per 0.1 of a unit.
Values in bold indicate statistical significance.
Factors associated with attempting to access secondary care (N = 1011)
| Characteristics | Attempted to access secondary care, | OR (95% CI) | Age and gender, aOR (95% CI) | Age, gender and deprivation, aOR (95% CI) | |
|---|---|---|---|---|---|
| Age (years) | ≤30 | 15 (62.5) |
| 2.30 (0.98, 5.39) | 2.16 (0.91, 5.11) |
| 31–45 | 104 (50.0) |
|
| 1.41 (1.00, 1.97) | |
| 46–64 | 174 (40.8) | 1 [ref] | 1 [ref] | 1 [ref] | |
| 65–74 | 98 (41.2) | 1.01 (0.73, 1.40) | 1.03 (0.75, 1.43) | 1.03 (0.75, 1.43) | |
| ≥75 | 47 (40.9) | 1.00 (0.66, 1.52) | 1.04 (0.68, 1.58) | 1.05 (0.69, 1.60) | |
| Gender | Male | 224 (40.7) | 0.79 (0.61, 1.01) | 0.83 (0.64, 1.08) | 0.83 (0.64, 1.07) |
| Female | 213 (46.5) | 1 [ref] | 1 [ref] | 1 [ref] | |
| Study cohort | BSRBR-AS | 260 (45.5) | 1 [ref] | 1 [ref] | 1 [ref] |
| MamMOTH | 96 (33.7) |
|
|
| |
| BSR-PsA | 82 (53.3) | 1.37 (0.96, 1.95) | 1.32 (0.92, 1.90) | 1.31 (0.91, 1.89) | |
| Deprivation | 1, most deprived | 43 (47.3) | 1.13 (0.70, 1.81) | 1.05 (0.65, 1.69) | 1.05 (0.65, 1.69) |
| 2 | 56 (43.1) | 0.95 (0.63, 1.45) | 0.94 (0.62, 1.43) | 0.94 (0.62, 1.43) | |
| 3 | 93 (45.8) | 1.06 (0.74, 1.53) | 1.05 (0.73, 1.52) | 1.05 (0.73, 1.52) | |
| 4 | 121 (39.7) | 0.83 (0.59, 1.15) | 0.84 (0.60, 1.17) | 0.84 (0.60, 1.17) | |
| 5, least deprived | 125 (44.3) | 1 [ref] | 1 [ref] | 1 [ref] | |
| Employment ( | Full time, including students and unpaid | 168 (42.8) | 1 [ref] | 1 [ref] | 1 [ref] |
| Part time | 68 (46.6) | 1.17 (0.80, 1.71) | 1.19 (0.80, 1.78) | 1.20 (0.80, 1.80) | |
| Retired | 134 (38.1) | 0.82 (0.61, 1.10) | 0.86 (0.53, 1.38) | 0.86 (0.53, 1.38) | |
| Unemployed, seeking work; Unemployed/retired early due to ill health | 66 (56.9) |
|
|
| |
| Residence | Urban | 319 (45.2) | 1 [ref] | 1 [ref] | 1 [ref] |
| Rural | 119 (38.9) | 0.77 (0.59, 1.01) | 0.79 (0.60, 1.05) | 0.80 (0.59, 1.07) | |
| CEV (shielded) ( | Advised and followed | 174 (52.3) |
|
|
|
| Not advised or not followed | 252 (38.4) | 1 [ref] | 1 [ref] | 1 [ref] | |
| Month of completion, 2020 | July | 163 (38.0) | 1 [ref] | 1 [ref] | 1 [ref] |
| August, September | 119 (47.2) |
|
|
| |
| October–December | 156 (47.3) |
|
|
| |
| Medication ( | bDMARD or tsDMARD | 169 (53.0) |
|
|
|
| cDMARD or steroids only | 84 (50.6) |
|
|
| |
| None of the above | 183 (35.1) | 1 [ref] | 1 [ref] | 1 [ref] | |
| PROMIS anxiety ( | Normal | 213 (37.1) | 1 [ref] | 1 [ref] | 1 [ref] |
| Mild | 115 (50.4) |
|
|
| |
| Moderate/severe | 105 (53.8) |
|
|
| |
| PROMIS depression ( | Normal | 235 (37.6) | 1 [ref] | 1 [ref] | 1 [ref] |
| Mild | 82 (48.5) |
|
|
| |
| Moderate/severe | 110 (56.7) |
|
|
| |
| EQ-5D | 0.62 (0.24) |
|
|
| |
EQ-5D: European Quality of Life 5-Dimensions questionnaire; ref: reference.
Mean (s.d.).
OR is per 0.1 of a unit.
Values in bold indicate statistical significance.
Factors associated with avoiding seeking healthcare (N = 997)
| Characteristics | Decided not to try to access healthcare, | OR (95% CI) | Age and gender, aOR (95% CI) | Age, gender and deprivation, aOR (95% CI) | |
|---|---|---|---|---|---|
| Age (years) | ≤30 | 4 (17.4) | 0.74 (0.25, 2.22) | 0.73 (0.24, 2.19) | 0.73 (0.24, 2.23) |
| 31–45 | 39 (18.9) | 0.82 (0.54, 1.24) | 0.81 (0.53, 1.24) | 0.80 (0.53, 1.23) | |
| 46–64 | 93 (22.2) | 1 [ref] | 1 [ref] | 1 [ref] | |
| 65–74 | 44 (19.0) | 0.82 (0.55, 1.23) | 0.83 (0.55, 1.24) | 0.83 (0.56, 1.25) | |
| ≥75 | 32 (27.4) | 1.32 (0.83, 2.11) | 1.33 (0.83, 2.14) | 1.35 (0.84, 2.16) | |
| Gender | Male | 113 (20.8) | 0.98 (0.72, 1.33) | 0.94 (0.69, 1.29) | 0.95 (0.70, 1.30) |
| Female | 97 (21.5) | 1 [ref] | 1 [ref] | 1 [ref] | |
| Previous study | BSRBR-AS | 105 (18.9) | 1 [ref] | 1 [ref] | 1 [ref] |
| MAmMOTH | 75 (26.5) |
|
|
| |
| BSRBR-PsA | 32 (21.2) | 1.17 (0.75, 1.83) | 1.19 (0.76, 1.87) | 1.18 (0.75, 1.86) | |
| Deprivation | 1, most deprived | 24 (26.4) | 1.62 (0.93, 2.83) | 1.71 (0.98, 3.01) | 1.71 (0.98, 3.01) |
| 2 | 23 (18.5) | 1.03 (0.60, 1.78) | 1.05 (0.61, 1.82) | 1.05 (0.61, 1.82) | |
| 3 | 42 (21.0) | 1.20 (0.76, 1.90) | 1.20 (0.76, 1.91) | 1.20 (0.76, 1.91) | |
| 4 | 72 (24.0) | 1.43 (0.96, 2.14) | 1.40 (0.93, 2.10) | 1.40 (0.93, 2.10) | |
| 5, least deprived | 51 (18.1) | 1 [ref] | 1 [ref] | 1 [ref] | |
| Employment ( | Full time, including students and unpaid | 74 (20.7) | 1 [ref] | 1 [ref] | 1 [ref] |
| Part time | 28 (19.3) | 0.92 (0.57, 1.49) | 0.87 (0.52, 1.44) | 0.85 (0.51, 1.42) | |
| Retired | 75 (21.5) | 1.05 (0.73, 1.51) | 0.96 (0.54, 1.71) | 0.96 (0.54, 1.72) | |
| Other | 34 (24.1) | 1.22 (0.77, 1.94) | 1.16 (0.72, 1.88) | 1.13 (0.70, 1.83) | |
| Residence | Urban | 140 (20.1) | 1 [Ref] | 1 [Ref] | 1 [Ref] |
| Rural | 72 (24.0) | 1.26 (0.91, 1.74) | 1.22 (0.88, 1.70) | 1.21 (0.86, 1.72) | |
| CEV ( | Advised and followed | 66 (19.9) | 0.88 (0.64, 1.23) | 0.86 (0.62, 1.20) | 0.85 (0.61, 1.18) |
| Not advised or not followed | 142 (22.0) | 1 [ref] | 1 [ref] | ||
| Month of completion, 2020 | July | 78 (18.4) | 1 [ref] | 1 [ref] | 1 [ref] |
| August, September | 72 (28.9) |
|
|
| |
| October–December | 62 (19.1) | 1.04 (0.72, 1.51) | 1.02 (0.70, 1.47) | 1.00 (0.69, 1.45) | |
| Medication ( | bDMARD or tsDMARD | 64 (20.2) | 0.87 (0.62, 1.22) | 0.90 (0.63, 1.29) | 0.91 (0.64, 1.30) |
| cDMARD or steroids only | 30 (18.5) | 0.78 (0.50, 1.22) | 0.77 (0.49, 1.20) | 0.79 (0.50, 1.23) | |
| None of the above | 116 (22.6) | 1 [ref] | 1 [ref] | 1 [ref] | |
| PROMIS anxiety ( | Normal | 108 (19.0) | 1 [ref] | 1 [ref] | 1 [ref] |
| Mild | 46 (20.4) | 1.09 (0.74, 1.61) | 1.13 (0.77, 1.68) | 1.11 (0.75, 1.64) | |
| Moderate/Severe | 56 (29.3) |
|
|
| |
| PROMIS depression ( | Normal | 120 (19.4) | 1 [ref] | 1 [ref] | 1 [ref] |
| Mild | 35 (21.0) | 1.10 (0.72, 1.68) | 1.13 (0.74, 1.73) | 1.13 (0.74, 1.74) | |
| Moderate/Severe | 49 (25.8) | 1.44 (0.99, 2.11) |
|
| |
| EQ-5D | Decided not to try to access | 0.64 (0.22) |
|
| 0.93 (0.87, 1.00) |
| Did not | 0.68 (0.22) | ||||
EQ-5D: European Quality of Life 5-Dimensions questionnaire; ref: reference.
Mean (s.d.).
OR is per 0.1 of a unit.
Values in bold indicate statistical significance.
Factors associated with satisfaction with remote healthcare consultation (N = 599)
| Characteristics | Satisfied with remote consult, | OR (95% CI) | Age and gender, aOR (95% CI) | Age, gender and deprivation, aOR (95% CI) | |
|---|---|---|---|---|---|
| Age (years) | ≤30 | 12 (63.2) | 0.48 (0.18, 1.27) | 0.45 (0.17, 1.21) | 0.40 (0.15, 1.11) |
| 31–45 | 108 (78.8) | 1.04 (0.62, 1.73) | 1.01 (0.60, 1.69) | 1.00 (0.59, 1.67) | |
| 46–64 | 187 (78.2) | 1 [ref] | 1 [ref] | 1 [ref] | |
| 65–74 | 112 (81.2) | 1.20 (0.71, 2.03) | 1.22 (0.72, 2.08) | 1.23 (0.72, 2.08) | |
| ≥75 | 48 (72.7) | 0.74 (0.40, 1.38) | 0.76 (0.41, 1.42) | 0.76 (0.40, 1.43) | |
| Gender | Male | 224 (76.7) | 0.86 (0.58, 1.26) | 0.84 (0.56, 1.25) | 0.84 (0.57, 1.26) |
| Female | 242 (79.3) | 1 [ref] | 1 [ref] | 1 [ref] | |
| Study cohort | BSRBR-AS | 257 (77.2) | 1 [ref] | 1 [ref] | 1 [ref] |
| MAmMOTH | 121 (77.6) | 1.02 (0.65, 1.61) | 0.96 (0.59, 1.58) | 0.96 (0.58, 1.58) | |
| BSR-PsA | 89 (80.9) | 1.25 (0.73, 2.15) | 1.17 (0.67, 2.04) | 1.12 (0.65, 1.96) | |
| Deprivation | 1, most | 39 (84.8) | 1.63 (0.68, 3.92) | 1.78 (0.72, 4.39) | 1.78 (0.72, 4.39) |
| 2 | 59 (74.7) | 0.86 (0.46, 1.60) | 0.85 (0.46, 1.59) | 0.85 (0.46, 1.59) | |
| 3 | 100 (80.0) | 1.17 (0.67, 2.05) | 1.16 (0.66, 2.04) | 1.16 (0.66, 2.04) | |
| 4 | 132 (76.7) | 0.97 (0.58, 1.59) | 0.90 (0.54, 1.50) | 0.90 (0.54, 1.50) | |
| 5, least | 137 (77.4) | 1 [ref] | 1 [ref] | 1 [ref] | |
| Employment ( | Full time, including students and unpaid | 178 (80.9) | 1 [ref] | 1 [ref] | 1 [ref] |
| Part time | 85 (84.2) | 1.25 (0.67, 2.36) | 0.99 (0.51, 1.94) | 0.98 (0.5, 1.92) | |
| Retired | 152 (74.9) | 0.70 (0.44, 1.12) | 0.33 (0.16, 0.68) | 0.32 (0.15, 0.67) | |
| Unemployed, seeking work; unemployed/retired early due to ill health | 51 (69.9) |
|
|
| |
| Residence | Urban | 326 (76.9) | 1 [ref] | 1 [ref] | 1 [ref] |
| Rural | 141 (80.6) | 1.25 (0.81, 1.93) | 1.24 (0.79, 1.93) | 1.31 (0.82, 2.09) | |
| Shielding ( | Advised and followed | 181 (79.7) | 1.18 (0.79, 1.78) | 1.17 (0.77, 1.76) | 1.13 (0.75, 1.71) |
| Not advised/not followed | 276 (76.9) | 1 [ref] | 1 [ref] | 1 [ref] | |
| Month of completion, 2020 | July | 188 (78.7) | 1 [ref] | 1 [ref] | 1 [ref] |
| August, September | 123 (76.9) | 0.90 (0.56, 1.46) | 0.86 (0.53, 1.41) | 0.88 (0.54, 1.43) | |
| October–December | 156 (78.0) | 0.96 (0.61, 1.52) | 0.95 (0.60, 1.51) | 0.94 (0.59, 1.50) | |
| Medication ( | bDMARD or tsDMARD | 172 (78.2) | 1.07 (0.70, 1.65) | 1.16 (0.74, 1.83) | 1.18 (0.74, 1.87) |
| cDMARD or steroids only | 87 (80.6) | 1.24 (0.71, 2.16) | 1.27 (0.73, 2.23) | 1.26 (0.72, 2.22) | |
| None of the above | 207 (77.0) | 1 [ref] | 1 [ref] | 1 [ref] | |
| PROMIS anxiety ( | Normal | 262 (82.9) | 1 [ref] | 1 [ref] | 1 [ref] |
| Mild | 108 (70.1) |
|
|
| |
| Moderate/severe | 91 (75.8) | 0.65 (0.39, 1.08) | 0.63 (0.37, 1.07) | 0.58 (0.34, 1.00) | |
| PROMIS depression ( | Normal | 291 (82.0) | 1 [ref] | 1 [ref] | 1 [ref] |
| Mild | 78 (74.3) | 0.64 (0.38, 1.06) | 0.62 (0.37, 1.04) | 0.62 (0.37, 1.05) | |
| Moderate/severe | 86 (69.9) |
|
|
| |
| EQ-5D | 0.66 (0.21) |
|
|
| |
EQ-5D: European Quality of Life 5-Dimensions questionnaire; ref: reference.
Mean (s.d.).
OR is per 0.1 of a unit.
Values in bold indicate statistical significance.